MX362089B - Nanopartículas que comprenden materiales metálicos y óxido de hafnio, preparación y usos de los mismos. - Google Patents
Nanopartículas que comprenden materiales metálicos y óxido de hafnio, preparación y usos de los mismos.Info
- Publication number
- MX362089B MX362089B MX2014007131A MX2014007131A MX362089B MX 362089 B MX362089 B MX 362089B MX 2014007131 A MX2014007131 A MX 2014007131A MX 2014007131 A MX2014007131 A MX 2014007131A MX 362089 B MX362089 B MX 362089B
- Authority
- MX
- Mexico
- Prior art keywords
- nanoparticles
- metallic
- hafnium oxide
- preparation
- relates
- Prior art date
Links
- 239000002105 nanoparticle Substances 0.000 title abstract 7
- 229910000449 hafnium oxide Inorganic materials 0.000 title abstract 2
- WIHZLLGSGQNAGK-UHFFFAOYSA-N hafnium(4+);oxygen(2-) Chemical compound [O-2].[O-2].[Hf+4] WIHZLLGSGQNAGK-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000463 material Substances 0.000 title abstract 2
- 229910044991 metal oxide Inorganic materials 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000007769 metal material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/242—Gold; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Nanotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Powder Metallurgy (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161576437P | 2011-12-16 | 2011-12-16 | |
| EP11193968 | 2011-12-16 | ||
| PCT/EP2012/075731 WO2013087920A1 (en) | 2011-12-16 | 2012-12-17 | Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014007131A MX2014007131A (es) | 2014-09-04 |
| MX362089B true MX362089B (es) | 2019-01-07 |
Family
ID=48611880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014007131A MX362089B (es) | 2011-12-16 | 2012-12-17 | Nanopartículas que comprenden materiales metálicos y óxido de hafnio, preparación y usos de los mismos. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10945965B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2790682B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6042450B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102025743B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN104093401B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012351537B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112014014412A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2857260C (cg-RX-API-DMAC7.html) |
| EA (1) | EA029635B1 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1203353A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL233035B (cg-RX-API-DMAC7.html) |
| MA (1) | MA35851B1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX362089B (cg-RX-API-DMAC7.html) |
| PL (1) | PL2790682T3 (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201403096VA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013087920A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3494974B1 (en) | 2011-07-08 | 2023-10-18 | The University of North Carolina at Chapel Hill | Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders |
| JP6042450B2 (ja) | 2011-12-16 | 2016-12-14 | ナノビオティックスＮａｎｏｂｉｏｔｉｘ | 金属材料および酸化ハフニウム材料を含むナノ粒子、その製造および使用 |
| PL2948179T3 (pl) | 2013-01-25 | 2019-10-31 | Nanobiotix | Kompozycje zawierające nanocząstki tlenku hafnu(iv) lub tlenku renu(iv) w połączeniu z promieniowaniem jonizującym do leczenia nowotworu |
| AU2014283217A1 (en) * | 2013-06-20 | 2015-12-24 | Nanobiotix | Compositions and methods for use in medical diagnosis |
| US10206871B2 (en) | 2014-10-14 | 2019-02-19 | The University Of Chicago | Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, chemotherapy, immunotherapy, and any combination thereof |
| US10806694B2 (en) * | 2014-10-14 | 2020-10-20 | The University Of Chicago | Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof |
| JP2018516256A (ja) * | 2015-05-28 | 2018-06-21 | ナノビオティックスＮａｎｏｂｉｏｔｉｘ | 治療用ワクチンとしての使用のためのナノ粒子 |
| US11389536B2 (en) * | 2015-07-17 | 2022-07-19 | BioCurity Pharmaceuticals Inc. | Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent |
| US9607952B1 (en) * | 2015-10-30 | 2017-03-28 | International Business Machines Corporation | High-z oxide nanoparticles embedded in semiconductor package |
| CN109310702A (zh) | 2016-05-20 | 2019-02-05 | 芝加哥大学 | 用于化学疗法、靶向疗法、光动力疗法、免疫疗法和它们的任何组合的纳米颗粒 |
| AU2017384425B2 (en) * | 2016-12-21 | 2023-08-31 | Nanobiotix | Nanoparticles for use for treating a neuronal disorder |
| WO2019028250A1 (en) | 2017-08-02 | 2019-02-07 | The University Of Chicago | NOMOGENEOUS ORGANOMETALLIC ORGANOMETRIC ORGANOMETRIC LAYERS FOR X-RAY INDUCED PHOTODYNAMIC THERAPY, RADIOTHERAPY, RODIODYNAMIC THERAPY, CHEMOTHERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF |
| JP7116563B2 (ja) * | 2018-03-16 | 2022-08-10 | 株式会社日本触媒 | 複合粒子 |
| CN109010828B (zh) * | 2018-10-12 | 2020-10-20 | 中国科学院高能物理研究所 | 一种二硫化钼/二氧化铪的复合纳米材料、其制备方法及用途 |
| EP4157457A1 (en) * | 2020-05-26 | 2023-04-05 | Nanobiotix | Nanoparticles, ionizing radiation and innovative therapeutic combinations thereof |
| CN112675305B (zh) * | 2021-01-22 | 2023-05-23 | 中国科学院深圳先进技术研究院 | 用于肿瘤治疗的双亲性分子自组装纳米药物及制备方法和用途 |
| US12245355B2 (en) | 2021-02-19 | 2025-03-04 | Mevion Medical Systems, Inc. | Gantry for a particle therapy system |
| AR131316A1 (es) | 2022-12-12 | 2025-03-05 | Nanobiotix S A | Novedosas nanopartículas de óxido de metal y composiciones de las mismas para uso como radiopotenciadores o para visualizar tejido biológico |
Family Cites Families (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4280918A (en) | 1980-03-10 | 1981-07-28 | International Business Machines Corporation | Magnetic particle dispersions |
| US4672040A (en) | 1983-05-12 | 1987-06-09 | Advanced Magnetics, Inc. | Magnetic particles for use in separations |
| US4770183A (en) | 1986-07-03 | 1988-09-13 | Advanced Magnetics Incorporated | Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents |
| US5225212A (en) | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
| US6099457A (en) * | 1990-08-13 | 2000-08-08 | Endotech, Inc. | Endocurietherapy |
| US5370901A (en) | 1991-02-15 | 1994-12-06 | Bracco International B.V. | Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients |
| JPH05209072A (ja) * | 1992-01-29 | 1993-08-20 | Japan Synthetic Rubber Co Ltd | 基材の表面処理方法 |
| JPH08500700A (ja) | 1992-06-08 | 1996-01-23 | バイオクエスト インコーポレイテッド | 分離、磁気分子スイッチ、および医療用途の無機リポソームとして使用する粒径を制御した無機粒子の製造 |
| EP0654973A4 (en) | 1992-07-21 | 1995-08-09 | Gen Hospital Corp | ARRANGEMENT FOR DELIVERING MEDICINES TO THE LYMPHIC TISSUE. |
| US5395619A (en) | 1993-03-03 | 1995-03-07 | Liposome Technology, Inc. | Lipid-polymer conjugates and liposomes |
| WO1998040049A2 (de) | 1997-03-07 | 1998-09-17 | Max-Delbrück-Centrum für Molekulare Medizin | Spezifische magnetosomen, verfahren zu ihrer herstellung und ihre verwendung |
| DE19716732C2 (de) | 1997-03-07 | 1999-03-25 | Max Delbrueck Centrum | Spezifische Magnetosomen, Verfahren zu ihrer Herstellung und ihre Verwendung |
| DE19726282A1 (de) | 1997-06-20 | 1998-12-24 | Inst Neue Mat Gemein Gmbh | Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern |
| US6200598B1 (en) | 1998-06-18 | 2001-03-13 | Duke University | Temperature-sensitive liposomal formulation |
| US6726925B1 (en) | 1998-06-18 | 2004-04-27 | Duke University | Temperature-sensitive liposomal formulation |
| WO2000006244A2 (en) | 1998-07-30 | 2000-02-10 | Hainfeld James F | Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy |
| US6514481B1 (en) | 1999-11-22 | 2003-02-04 | The Research Foundation Of State University Of New York | Magnetic nanoparticles for selective therapy |
| JP5074652B2 (ja) | 2000-02-08 | 2012-11-14 | ライスユニバーシティ | 治療法および診断法において使用される光学活性なナノ粒子 |
| WO2002087509A2 (en) | 2001-04-30 | 2002-11-07 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
| DE10154016B4 (de) | 2001-10-26 | 2004-02-12 | Berlin Heart Ag | Magnetflüssigkeit und Verfahren zur ihrer Herstellung |
| AU2002351240A1 (en) * | 2002-03-08 | 2003-09-22 | James Hainfeld | Gold nanoparticles used for x-rays imaging |
| US7769423B2 (en) | 2002-09-11 | 2010-08-03 | Duke University | MRI imageable liposomes for the evaluation of treatment efficacy, thermal distribution, and demonstration of dose painting |
| US20030125283A1 (en) | 2002-09-16 | 2003-07-03 | Gatenby Robert A. | Therapy of proliferative disorders by direct irradiation of cell nuclei with tritiated nuclear targetting agents |
| US7235228B2 (en) | 2003-04-15 | 2007-06-26 | The United States Of America As Represented By The Secretary Of The Navy | Fluorescent-magnetic nanoparticles with core-shell structure |
| US20050084869A1 (en) | 2003-10-20 | 2005-04-21 | Sung Hyun Kim | Novel composition and methods for the diagnosis of lung cancer |
| WO2005046733A1 (en) | 2003-11-17 | 2005-05-26 | Philips Intellectual Property & Standards Gmbh | Contrast agent for medical imaging techniques and usage thereof |
| CA2547024C (en) | 2003-12-22 | 2013-12-17 | Bracco Research Sa | Gas-filled microvesicle assembly for contrast imaging |
| JP4895151B2 (ja) | 2004-02-27 | 2012-03-14 | 日立金属株式会社 | 鉄系ナノサイズ粒子およびその製造方法 |
| FR2869803B1 (fr) | 2004-05-10 | 2006-07-28 | Nanobiotix Sarl | Particules activables, preparation et utilisations |
| US20050260137A1 (en) | 2004-05-18 | 2005-11-24 | General Electric Company | Contrast agents for magnetic resonance imaging |
| US20070031337A1 (en) | 2004-06-22 | 2007-02-08 | Reinhard Schulte | Nanoparticle enhanced proton computed tomography and proton therapy |
| GB2415374A (en) | 2004-06-25 | 2005-12-28 | Leuven K U Res & Dev | Targeted delivery of biologically active substances using iron oxide/gold core-shell nanoparticles |
| WO2006037081A2 (en) * | 2004-09-28 | 2006-04-06 | The Regents Of The University Of California | Nanoparticle radiosensitizers |
| EP1810688A1 (en) | 2004-11-10 | 2007-07-25 | Konica Minolta Medical & Graphic, Inc. | Pharmaceutical preparation containing coated magnetic particles and method for production thereof, and diagnosis therapy system |
| US20070092927A1 (en) | 2005-06-13 | 2007-04-26 | University Of Dayton | Photocatalytic particles with directed and controlled redox activity |
| WO2007052267A2 (en) | 2005-11-01 | 2007-05-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Biodegradable composite for internal local radiotherapy |
| US20070098641A1 (en) * | 2005-11-02 | 2007-05-03 | General Electric Company | Nanoparticle-based imaging agents for X-ray/computed tomography |
| KR100745744B1 (ko) * | 2005-11-11 | 2007-08-02 | 삼성전기주식회사 | 나노 입자 코팅 방법 |
| WO2007122956A1 (ja) | 2006-03-24 | 2007-11-01 | Toto Ltd. | 酸化チタン複合体粒子、その分散液、およびそれらの製造方法 |
| JP2009536151A (ja) | 2006-03-30 | 2009-10-08 | 富士フイルム株式会社 | ナノ粒子 |
| EP1852107A1 (en) | 2006-04-19 | 2007-11-07 | Nanobiotix | Magnetic nanoparticles compositions and uses thereof |
| RU2009104312A (ru) | 2006-07-10 | 2010-08-20 | Конинклейке Филипс Электроникс Н.В. (Nl) | Наночастицы типа "ядро-оболочка" для терапии и диагностических целей |
| DE102006041495A1 (de) | 2006-08-29 | 2008-03-20 | Friedrich-Schiller-Universität Jena | Substanzgemisch zur lokalen Deposition von Magnetpartikeln in einem Medium, insbesondere in tumorbefallenem organischem Gewebe, sowie Applikationskit zur Verabreichung |
| NO329127B1 (no) | 2006-09-12 | 2010-08-30 | Epitarget As | Sporbart partikulaert materiale for legemiddelavlevering omfattende et matriseeller membranmateriale, et legemiddel, og et T1- og et T2*- magnetisk resonanskontrastmiddel |
| NO20064315L (no) | 2006-09-22 | 2008-03-24 | Epitarget As | T1 MRI-sporbare medikamentavleveringspartikler and anvendelse derav |
| EP1920784A1 (en) | 2006-11-13 | 2008-05-14 | Koninklijke Philips Electronics N.V. | Radiation sensitizers in ionizing radiation therapy and imaging |
| US20090004258A1 (en) | 2007-06-27 | 2009-01-01 | National Health Research Institutes | Drug Release from Thermosensitive Liposomes by Applying an Alternative Magnetic Field |
| JP2009067613A (ja) | 2007-09-11 | 2009-04-02 | Fujifilm Corp | コア−シェル型金属酸化物微粒子及びその製造方法 |
| US20120176016A1 (en) * | 2007-09-28 | 2012-07-12 | General Electric Company | Core-shell particulates, articles, and method of making |
| FR2922106B1 (fr) | 2007-10-16 | 2011-07-01 | Univ Claude Bernard Lyon | Utilisation de nanoparticules a base de lanthanides comme agents radiosensibilisants. |
| EP2067485A1 (en) | 2007-12-07 | 2009-06-10 | Koninklijke Philips Electronics N.V. | Drug carrier providing MRI contrast enhancement |
| WO2009081287A2 (en) | 2007-12-21 | 2009-07-02 | University Of Guelph | Polysaccharide nanoparticles |
| US20110052672A1 (en) | 2008-01-16 | 2011-03-03 | Sunil Krishnan | Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy |
| DE102008008522A1 (de) | 2008-02-11 | 2009-08-13 | Magforce Nanotechnologies Ag | Implantierbare Nanopartikel-enthaltende Produkte |
| WO2009142754A1 (en) | 2008-05-22 | 2009-11-26 | Goverment Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Dendritic conjugates and methods of use |
| EP2130553A1 (en) | 2008-06-05 | 2009-12-09 | Nanobiotix | Inorganic nanoparticles of high density to destroy cells in-vivo |
| GB0811300D0 (en) * | 2008-06-19 | 2008-07-30 | Syngenta Participations Ag | Methods of controlling neonicotinoid resistant insects |
| US20130023714A1 (en) | 2008-10-26 | 2013-01-24 | Board Of Regents, The University Of Texas Systems | Medical and Imaging Nanoclusters |
| EP2275137A1 (en) * | 2009-07-10 | 2011-01-19 | Nanobiotix | Metallic nanoparticles, preparation and uses thereof |
| EP2305310A1 (en) | 2009-09-25 | 2011-04-06 | Asociación Centro de Investigación Cooperativa en Biomateriales - CIC biomaGUNE | Gold -coated magnetic glyconanoparticles functionalised with proteins for use as diagnostic and therapeutic agents |
| GB0921596D0 (en) | 2009-12-09 | 2010-01-27 | Isis Innovation | Particles for the treatment of cancer in combination with radiotherapy |
| US8580312B2 (en) | 2010-02-17 | 2013-11-12 | National University Corporation Kobe University | Radiation therapy agent |
| US20130225901A1 (en) | 2010-04-05 | 2013-08-29 | Nanospectra Biosciences, Inc. | Enhancement of radiation therapy by targeted high-z nanoparticles |
| GB201009455D0 (en) | 2010-06-04 | 2010-07-21 | King S College London | Nanoparticles and their uses in molecular imaging |
| CN103429227B (zh) | 2011-01-31 | 2017-12-19 | 纳米生物技术公司 | 纳米粒子递送系统、其制备及应用 |
| EP2670393B8 (en) | 2011-01-31 | 2016-10-05 | Nanobiotix | Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles. |
| JP6042450B2 (ja) | 2011-12-16 | 2016-12-14 | ナノビオティックスＮａｎｏｂｉｏｔｉｘ | 金属材料および酸化ハフニウム材料を含むナノ粒子、その製造および使用 |
| PL2948179T3 (pl) | 2013-01-25 | 2019-10-31 | Nanobiotix | Kompozycje zawierające nanocząstki tlenku hafnu(iv) lub tlenku renu(iv) w połączeniu z promieniowaniem jonizującym do leczenia nowotworu |
| US20140219926A1 (en) | 2013-02-01 | 2014-08-07 | The Trustees Of Dartmouth College | Biodegradable Iron Oxide Nanoparticle Gel for Tumor Bed Therapy |
| MA38687A1 (fr) | 2013-05-30 | 2017-12-29 | Nanobiotix | Composition pharmaceutique, préparation et utilisations de celle-ci |
| WO2014202738A1 (en) | 2013-06-20 | 2014-12-24 | Nanobiotix | Compositions and methods for use in oncology |
| AU2014283217A1 (en) | 2013-06-20 | 2015-12-24 | Nanobiotix | Compositions and methods for use in medical diagnosis |
| EP2886128A1 (en) | 2013-12-20 | 2015-06-24 | Nanobiotix | Pharmaceutical composition comprising nanoparticles, preparation and uses thereof |
-
2012
- 2012-12-17 JP JP2014546562A patent/JP6042450B2/ja active Active
- 2012-12-17 EA EA201491199A patent/EA029635B1/ru not_active IP Right Cessation
- 2012-12-17 CN CN201280062223.XA patent/CN104093401B/zh active Active
- 2012-12-17 AU AU2012351537A patent/AU2012351537B2/en active Active
- 2012-12-17 HK HK15103694.6A patent/HK1203353A1/xx unknown
- 2012-12-17 CA CA2857260A patent/CA2857260C/en active Active
- 2012-12-17 MX MX2014007131A patent/MX362089B/es active IP Right Grant
- 2012-12-17 US US14/364,859 patent/US10945965B2/en active Active
- 2012-12-17 EP EP12806026.6A patent/EP2790682B1/en active Active
- 2012-12-17 KR KR1020147019571A patent/KR102025743B1/ko active Active
- 2012-12-17 SG SG11201403096VA patent/SG11201403096VA/en unknown
- 2012-12-17 PL PL12806026T patent/PL2790682T3/pl unknown
- 2012-12-17 WO PCT/EP2012/075731 patent/WO2013087920A1/en not_active Ceased
- 2012-12-17 BR BR112014014412A patent/BR112014014412A2/pt not_active Application Discontinuation
-
2014
- 2014-06-09 IL IL233035A patent/IL233035B/en active IP Right Grant
- 2014-07-09 MA MA37185A patent/MA35851B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA029635B1 (ru) | 2018-04-30 |
| AU2012351537A1 (en) | 2014-07-24 |
| NZ625848A (en) | 2015-04-24 |
| MA35851B1 (fr) | 2014-12-01 |
| MX2014007131A (es) | 2014-09-04 |
| SG11201403096VA (en) | 2014-07-30 |
| CN104093401A (zh) | 2014-10-08 |
| US10945965B2 (en) | 2021-03-16 |
| IL233035A0 (en) | 2014-07-31 |
| JP6042450B2 (ja) | 2016-12-14 |
| IL233035B (en) | 2018-02-28 |
| EP2790682A1 (en) | 2014-10-22 |
| EP2790682B1 (en) | 2019-03-20 |
| KR102025743B1 (ko) | 2019-09-26 |
| WO2013087920A1 (en) | 2013-06-20 |
| KR20140108685A (ko) | 2014-09-12 |
| HK1203353A1 (en) | 2015-10-30 |
| US20140335015A1 (en) | 2014-11-13 |
| BR112014014412A2 (pt) | 2017-06-13 |
| CA2857260C (en) | 2019-10-15 |
| EA201491199A1 (ru) | 2014-11-28 |
| CN104093401B (zh) | 2018-06-29 |
| JP2015509079A (ja) | 2015-03-26 |
| CA2857260A1 (en) | 2013-06-20 |
| AU2012351537B2 (en) | 2017-03-02 |
| PL2790682T3 (pl) | 2019-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1203353A1 (en) | Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof | |
| IL272313A (en) | Intravascular delivery of nanoparticle preparations and their uses | |
| IL261338A (en) | Preparations and methods for treating broad-spectrum, undiagnosed or mixed clinical applications | |
| WO2010091262A8 (en) | Chimeric newcastle disease viruses and uses thereof | |
| MY164356A (en) | Substituted 5-fluoro-1h-pyrazolopyridines and their use | |
| CA2863681A1 (en) | Topical use of a skin-commensal prebiotic agent and compositions containing the same | |
| WO2012177757A3 (en) | Personal care compositions comprising shaped abrasive particles | |
| IL236123A0 (en) | Preparations containing n-[4,2-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-4,1-dihydro-4-oxoquinoline-3-carboxamide for use in the treatment of cftr-mediated disorders | |
| WO2014062720A3 (en) | Methods of treating cancer | |
| IL236892A0 (en) | A preparation containing two engineered antibodies to allow reduced or increased effector activity | |
| IL219876A (en) | Antibody or fragment thereof against human b7-h1, compositions comprising same and use thereof in the preparation of medicaments | |
| IL231536A (en) | Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases | |
| IN2015DN00392A (cg-RX-API-DMAC7.html) | ||
| MX2019000225A (es) | Composiciones y metodos para el tratamiento de enfermedades autoinmunes y otras enfermedades. | |
| PT2555763E (pt) | Composições inibidoras virais para utilização terapêutica in vivo que compreendem uma combinação de (-)-carvona, (+)- carnona, geraniol e um componente de óleo essencial adicional | |
| IL248880B (en) | Preparations containing r-g-cysteic acid peptides and their uses for the treatment of eye diseases | |
| WO2012121528A3 (en) | Magnetic nanocomposite specific for thyroid cancer and use thereof | |
| IL220974A0 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| GB2548034B (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
| PL2768936T3 (pl) | Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie | |
| WO2012095399A3 (en) | Personal care compositions | |
| WO2012098562A3 (en) | Liquid oral compositions of lanthanum salts | |
| EP3150632A3 (en) | Anti-ricin antibodies and uses thereof | |
| WO2012093973A3 (en) | Compositions in the form of tablets comprising acarbose | |
| EP3456837A3 (en) | Decorin compositions and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |